Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Comparative effects of photobiomodulation therapy at wavelengths of 660 and 808 nm on regeneration of inferior alveolar nerve in rats following crush injury.

Diker N, Aytac D, Helvacioglu F, Oguz Y.

Lasers Med Sci. 2019 Jul 4. doi: 10.1007/s10103-019-02838-w. [Epub ahead of print]

PMID:
31273571
2.

Evaluation of the Effects of Low-Level Laser Therapy on Diabetic Bone Healing.

Diker N, Aytac D, Helvacioglu F, Dagdelen C, Oguz Y.

J Craniofac Surg. 2019 Jun 20. doi: 10.1097/SCS.0000000000005654. [Epub ahead of print]

PMID:
31232987
3.

Can Variable Plasma Volume Alterations Affect the Efficiency of the First Trimester Screening Test?

Öcal DF, Yakut K, Öztürk M, Oğuz Y, Özkaya E, Toptaş G, Tosun A, Küçüközkan T.

Clin Lab. 2019 Jun 1;65(6). doi: 10.7754/Clin.Lab.2018.181124.

PMID:
31232018
4.

Odontogenic effects of two calcium silicate-based biomaterials in human dental pulp cells.

Önay EO, Yurtcu E, Terzi YK, Üngör M, Oguz Y, Şahin FI.

Adv Clin Exp Med. 2018 Nov;27(11):1541-1547. doi: 10.17219/acem/74197.

5.

The effect of swim-up and gradient sperm preparation techniques on deoxyribonucleic acid (DNA) fragmentation in subfertile patients.

Oguz Y, Guler I, Erdem A, Mutlu MF, Gumuslu S, Oktem M, Bozkurt N, Erdem M.

J Assist Reprod Genet. 2018 Jun;35(6):1083-1089. doi: 10.1007/s10815-018-1163-z. Epub 2018 Mar 23.

6.

Effects of Hyaluronic Acid and Hydroxyapatite/Beta-tricalcium Phosphate in Combination on Bone Regeneration of a Critical-size Defect in an Experimental Model.

Diker N, Gulsever S, Koroglu T, Yilmaz Akcay E, Oguz Y.

J Craniofac Surg. 2018 Jun;29(4):1087-1093. doi: 10.1097/SCS.0000000000004338.

PMID:
29438204
7.

The association of profilin-1 levels with survival in chronic kidney disease.

Eroglu E, Unal HU, Guclu A, Kocyigit I, Karaman M, Saglam M, Gezer M, Tas A, Zararsiz G, Eyileten T, Aydin İ, Oguz Y, Gungor O, Yilmaz MI.

Eur J Clin Invest. 2017 Dec;47(12). doi: 10.1111/eci.12839. Epub 2017 Oct 27.

PMID:
28981140
8.

IL-33 and ST2 levels in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events, and survival.

Gungor O, Unal HU, Guclu A, Gezer M, Eyileten T, Guzel FB, Altunoren O, Erken E, Oguz Y, Kocyigit I, Yilmaz MI.

PLoS One. 2017 Jun 14;12(6):e0178939. doi: 10.1371/journal.pone.0178939. eCollection 2017.

9.

The Impact of laparoscopic surgery of peritoneal endometriosis and endometrioma on the outcome of ICSI cycles.

Guler I, Erdem A, Oguz Y, Cevher F, Mutlu MF, Bozkurt N, Oktem M, Erdem M.

Syst Biol Reprod Med. 2017 Oct;63(5):324-330. doi: 10.1080/19396368.2017.1332114. Epub 2017 Jun 13.

PMID:
28609124
10.

Endostatin in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events and survival.

Kanbay M, Afsar B, Siriopol D, Unal HU, Karaman M, Saglam M, Gezer M, Taş A, Eyileten T, Guler AK, Aydin İ, Oguz Y, Tarim K, Covic A, Yilmaz MI.

Eur J Intern Med. 2016 Sep;33:81-7. doi: 10.1016/j.ejim.2016.06.033. Epub 2016 Jul 7.

PMID:
27394925
11.

Mechanical evaluation of six techniques for stable fixation of the sagittal split osteotomy after counterclockwise mandibular advancement.

De Oliveira LB, Reis JM, Spin-Neto R, Gabrielli MA, Oguz Y, Pereira-Filho VA.

Br J Oral Maxillofac Surg. 2016 Jun;54(5):573-8. doi: 10.1016/j.bjoms.2016.03.002. Epub 2016 Apr 7.

PMID:
27068853
12.

Thyroid function and cardiovascular events in chronic kidney disease patients.

Afsar B, Yilmaz MI, Siriopol D, Unal HU, Saglam M, Karaman M, Gezer M, Sonmez A, Eyileten T, Aydin I, Hamcan S, Oguz Y, Covic A, Kanbay M.

J Nephrol. 2017 Apr;30(2):235-242. doi: 10.1007/s40620-016-0300-y. Epub 2016 Apr 2.

PMID:
27039198
13.

Osteoprotegerin in Chronic Kidney Disease: Associations with Vascular Damage and Cardiovascular Events.

Yilmaz MI, Siriopol D, Saglam M, Unal HU, Karaman M, Gezer M, Kilinc A, Eyileten T, Guler AK, Aydin İ, Vural A, Oguz Y, Covic A, Ortiz A, Kanbay M.

Calcif Tissue Int. 2016 Aug;99(2):121-30. doi: 10.1007/s00223-016-0136-4. Epub 2016 Mar 26.

PMID:
27016924
14.

Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.

Kanbay M, Afsar B, Siriopol D, Unal HU, Karaman M, Saglam M, Eyileten T, Gezer M, Verim S, Oguz Y, Vural A, Ortiz A, Johnson RJ, Covic A, Yilmaz MI.

Int Urol Nephrol. 2016 Jul;48(7):1129-36. doi: 10.1007/s11255-016-1271-6. Epub 2016 Mar 23.

PMID:
27007614
15.

Incidence of root canal treatment of second molars following adjacent impacted third molar extraction.

Oguz Y, Soydan SS, Onay EO, Cubuk S.

J Dent Sci. 2016 Mar;11(1):90-94. doi: 10.1016/j.jds.2015.04.005. Epub 2015 Aug 3.

16.

Ultrasonographic evaluation of the femoral cartilage thickness in patients with chronic renal failure.

Ünal HU, Tok F, Adıgüzel E, Gezer M, Aydın İ, Yılmaz B, Oğuz Y.

Ren Fail. 2016;38(4):600-4. doi: 10.3109/0886022X.2016.1149685. Epub 2016 Feb 24.

PMID:
26905953
17.

The impact of expectant management, systemic methotrexate and surgery on subsequent pregnancy outcomes in tubal ectopic pregnancy.

Demirdag E, Guler I, Abay S, Oguz Y, Erdem M, Erdem A.

Ir J Med Sci. 2017 May;186(2):387-392. doi: 10.1007/s11845-016-1419-5. Epub 2016 Feb 19.

PMID:
26895299
18.

Stress Distribution on Short Implants at Maxillary Posterior Alveolar Bone Model With Different Bone-to-Implant Contact Ratio: Finite Element Analysis.

Yazicioglu D, Bayram B, Oguz Y, Cinar D, Uckan S.

J Oral Implantol. 2016 Feb;42(1):26-33. doi: 10.1563/aaid-doi-D-14-00003.

PMID:
26867093
19.

The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.

Sonmez A, Yilmaz MI, Saglam M, Unal HU, Gok M, Cetinkaya H, Karaman M, Haymana C, Eyileten T, Oguz Y, Vural A, Rizzo M, Toth PP.

Lipids Health Dis. 2015 Apr 16;14:29. doi: 10.1186/s12944-015-0031-4.

20.

In vitro biomechanical comparison of six different fixation methods following 5-mm sagittal split advancement osteotomies.

Oguz Y, Watanabe ER, Reis JM, Spin-Neto R, Gabrielli MA, Pereira-Filho VA.

Int J Oral Maxillofac Surg. 2015 Aug;44(8):984-8. doi: 10.1016/j.ijom.2014.11.019. Epub 2015 Apr 1.

PMID:
25840861
21.

Stress Distribution on Short Implants at Maxillary Posterior Alveolar Bone Model with Different Bone-to-Implant Contact Ratio: Finite Element Analysis.

Yazicioglu D, Bayram B, Oguz Y, Cinar D, Uckan S.

J Oral Implantol. 2015 Feb 2. [Epub ahead of print]

PMID:
25643163
22.

A longitudinal study of inflammation, CKD-mineral bone disorder, and carotid atherosclerosis after renal transplantation.

Yilmaz MI, Sonmez A, Saglam M, Cayci T, Kilic S, Unal HU, Karaman M, Cetinkaya H, Eyileten T, Gok M, Oguz Y, Vural A, Mallamaci F, Zoccali C.

Clin J Am Soc Nephrol. 2015 Mar 6;10(3):471-9. doi: 10.2215/CJN.07860814. Epub 2014 Dec 26.

23.

Ramipril lowers plasma FGF-23 in patients with diabetic nephropathy.

Yilmaz MI, Sonmez A, Saglam M, Kurt YG, Unal HU, Karaman M, Gok M, Cetinkaya H, Eyileten T, Oguz Y, Vural A, Mallamaci F, Zoccali C.

Am J Nephrol. 2014;40(3):208-14. doi: 10.1159/000366169. Epub 2014 Oct 10.

24.

Mitral annular calcification and the serum osteocalcin level in patients with chronic kidney disease.

Unal HU, Çelik M, Gökoğlan Y, Çetinkaya H, Gök M, Karaman M, Yilmaz Mİ, Eyileten T, Oğuz Y.

Ren Fail. 2014 Nov;36(10):1481-5. doi: 10.3109/0886022X.2014.962421. Epub 2014 Sep 16.

PMID:
25224152
25.

Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients.

Kanbay M, Siriopol D, Saglam M, Kurt YG, Gok M, Cetinkaya H, Karaman M, Unal HU, Oguz Y, Sari S, Eyileten T, Goldsmith D, Vural A, Veisa G, Covic A, Yilmaz MI.

J Clin Endocrinol Metab. 2014 Oct;99(10):E1854-61. doi: 10.1210/jc.2014-2042. Epub 2014 Jul 24.

PMID:
25057883
26.

Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease.

Yilmaz MI, Siriopol D, Saglam M, Kurt YG, Unal HU, Eyileten T, Gok M, Cetinkaya H, Oguz Y, Sari S, Vural A, Mititiuc I, Covic A, Kanbay M.

Kidney Int. 2014 Dec;86(6):1213-20. doi: 10.1038/ki.2014.227. Epub 2014 Jul 2.

27.

Autofluorescence patterns as a predictive factor for neovascularization.

Batioğlu F, Demirel S, Ozmert E, Oguz YG, Ozyol P.

Optom Vis Sci. 2014 Aug;91(8):950-5. doi: 10.1097/OPX.0000000000000321.

PMID:
24987815
28.

Endothelial function in patients with familial Mediterranean fever-related amyloidosis and association with cardiovascular events.

Yilmaz MI, Demirkaya E, Acikel C, Saldir M, Akar S, Cayci T, Saglam M, Unal HU, Gok M, Polat A, Cetinkaya H, Eyileten T, Sari S, Yildirim AO, Sonmez A, Oguz Y, Vural A, Ozen S, Carrero JJ.

Rheumatology (Oxford). 2014 Nov;53(11):2002-8. doi: 10.1093/rheumatology/keu231. Epub 2014 Jun 6.

PMID:
24907154
29.

Radiological and Histological Evaluation of the Effects of Cortical Perforations on Bone Healing in Mandibular Onlay Graft Procedures.

Dayangac E, Araz K, Oguz Y, Bacanli D, Caylak B, Uckan S.

Clin Implant Dent Relat Res. 2016 Feb;18(1):82-8. doi: 10.1111/cid.12238. Epub 2014 May 29.

PMID:
24889104
30.

Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease.

Kanbay M, Solak Y, Unal HU, Kurt YG, Gok M, Cetinkaya H, Karaman M, Oguz Y, Eyileten T, Vural A, Covic A, Goldsmith D, Turak O, Yilmaz MI.

Int Urol Nephrol. 2014 Aug;46(8):1619-25. doi: 10.1007/s11255-014-0730-1. Epub 2014 May 23.

PMID:
24853998
31.

The relationship between IL-10 levels and cardiovascular events in patients with CKD.

Yilmaz MI, Solak Y, Saglam M, Cayci T, Acikel C, Unal HU, Eyileten T, Oguz Y, Sari S, Carrero JJ, Stenvinkel P, Covic A, Kanbay M.

Clin J Am Soc Nephrol. 2014 Jul;9(7):1207-16. doi: 10.2215/CJN.08660813. Epub 2014 May 1.

32.

Power quality control and design of power converter for variable-speed wind energy conversion system with permanent-magnet synchronous generator.

Oğuz Y, Güney İ, Çalık H.

ScientificWorldJournal. 2013 Dec 22;2013:783010. doi: 10.1155/2013/783010. eCollection 2013.

33.

Soluble TWEAK plasma levels increase after renal transplantation and associate with the improvement of endothelial function.

Yilmaz MI, Sonmez A, Saglam M, Yaman H, Unal HU, Gok M, Cetinkaya H, Eyileten T, Oguz Y, Sari S, Yildirim AO, Vural A, Carrero JJ, Blanco-Colio LM.

Eur J Clin Invest. 2013 Dec;43(12):1250-7. doi: 10.1111/eci.12166. Epub 2013 Sep 20.

PMID:
24112080
34.

Macular Involvement and Response to Steroid Therapy Demonstrated by Optical Coherence Tomography in Non-arteritic Anterior Ischaemic Optic Neuropathy.

Demirel S, Batıoğlu F, Oguz YG, Özmert E.

Neuroophthalmology. 2013 Jul 25;37(4):161-164. doi: 10.3109/01658107.2013.809365. eCollection 2013.

35.

Mean corpuscular volume is associated with endothelial dysfunction and predicts composite cardiovascular events in patients with chronic kidney disease.

Solak Y, Yilmaz MI, Saglam M, Demirbas S, Verim S, Unal HU, Gaipov A, Oguz Y, Kayrak M, Caglar K, Vural A, Turk S, Covic A, Kanbay M.

Nephrology (Carlton). 2013 Nov;18(11):728-35. doi: 10.1111/nep.12130.

PMID:
23848392
36.

Removal of fractured implants and replacement with new ones.

Oguz Y, Cinar D, Bayram B.

J Oral Implantol. 2015 Feb;41(1):85-7. doi: 10.1563/AAID-JOI-D-12-00249. Epub 2013 Feb 18. No abstract available.

PMID:
23418902
37.

Longitudinal analysis of vascular function and biomarkers of metabolic bone disorders before and after renal transplantation.

Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Turker T, Unal HU, Gok M, Cetinkaya H, Eyileten T, Oguz Y, Caglar K, Vural A, Mallamaci F, Zoccali C.

Am J Nephrol. 2013;37(2):126-34. doi: 10.1159/000346711. Epub 2013 Jan 31.

PMID:
23391995
38.

Neutrophil to lymphocyte ratio independently predicts cardiovascular events in patients with chronic kidney disease.

Solak Y, Yilmaz MI, Sonmez A, Saglam M, Cakir E, Unal HU, Gok M, Caglar K, Oguz Y, Yenicesu M, Karaman M, Ay SA, Gaipov A, Turk S, Vural A, Carrero JJ.

Clin Exp Nephrol. 2013 Aug;17(4):532-40. doi: 10.1007/s10157-012-0728-x. Epub 2012 Nov 20.

PMID:
23180042
39.

Are success and survival rates of early implant placement higher than immediate implant placement?

Soydan SS, Cubuk S, Oguz Y, Uckan S.

Int J Oral Maxillofac Surg. 2013 Apr;42(4):511-5. doi: 10.1016/j.ijom.2012.10.014. Epub 2012 Nov 8.

PMID:
23142021
40.

Serum uric acid independently predicts cardiovascular events in advanced nephropathy.

Kanbay M, Yilmaz MI, Sonmez A, Solak Y, Saglam M, Cakir E, Unal HU, Arslan E, Verim S, Madero M, Caglar K, Oguz Y, McFann K, Johnson RJ.

Am J Nephrol. 2012;36(4):324-31. doi: 10.1159/000342390. Epub 2012 Sep 22.

41.

Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients.

Kanbay M, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU, Gok M, Caglar K, Oguz Y, Yenicesu M, Cetinkaya H, Eyileten T, Acikel C, Vural A, Covic A.

Am J Nephrol. 2012;36(3):228-37. Epub 2012 Aug 30.

PMID:
22948239
42.

Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial.

Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Mallamaci F, Zoccali C.

Am J Kidney Dis. 2012 Feb;59(2):177-85. doi: 10.1053/j.ajkd.2011.11.007. Epub 2011 Dec 2.

PMID:
22137672
43.

Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease.

Yilmaz MI, Sonmez A, Qureshi AR, Saglam M, Stenvinkel P, Yaman H, Eyileten T, Caglar K, Oguz Y, Taslipinar A, Vural A, Gok M, Unal HU, Yenicesu M, Carrero JJ.

Clin J Am Soc Nephrol. 2011 Jul;6(7):1617-25. doi: 10.2215/CJN.10681210. Epub 2011 Jun 23.

44.

Repositioning a prosthetically unfavorable implant by vertical distraction osteogenesis.

Oduncuoglu BF, Alaaddinoglu EE, Oguz Y, Uckan S, Erkut S.

J Oral Maxillofac Surg. 2011 Jun;69(6):1628-32. doi: 10.1016/j.joms.2010.12.025. Epub 2011 Apr 5.

PMID:
21470742
45.

Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes.

Yilmaz MI, Stenvinkel P, Sonmez A, Saglam M, Yaman H, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Çakar M, Altun B, Yenicesu M, Carrero JJ.

Nephrol Dial Transplant. 2011 Nov;26(11):3537-43. doi: 10.1093/ndt/gfr081. Epub 2011 Mar 4.

PMID:
21378154
46.

Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes.

Yilmaz MI, Sonmez A, Ortiz A, Saglam M, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Çakar M, Egido J, Altun B, Yenicesu M, Blanco-Colio LM, Carrero JJ.

Clin J Am Soc Nephrol. 2011 Apr;6(4):785-92. doi: 10.2215/CJN.09231010. Epub 2011 Feb 17.

47.

Low triiodothyronine alters flow-mediated vasodilatation in advanced nondiabetic kidney disease.

Yilmaz MI, Sonmez A, Karaman M, Ay SA, Saglam M, Yaman H, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Zoccali C.

Am J Nephrol. 2011;33(1):25-32. doi: 10.1159/000322581. Epub 2010 Dec 9.

PMID:
21150192
48.

FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease.

Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Demirkaya E, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Zoccali C.

Kidney Int. 2010 Oct;78(7):679-85. doi: 10.1038/ki.2010.194. Epub 2010 Jul 7.

49.

Effect of renin-angiotensin-aldosterone system (RAAS) blockade on visfatin levels in diabetic nephropathy.

Eyileten T, Sonmez A, Saglam M, Cakir E, Caglar K, Oguz Y, Vural A, Yenicesu M, Yilmaz MI.

Nephrology (Carlton). 2010 Mar;15(2):225-9. doi: 10.1111/j.1440-1797.2009.01173.x.

PMID:
20470283
50.

Reduced proteinuria using ramipril in diabetic CKD stage 1 decreases circulating cell death receptor activators concurrently with ADMA. A novel pathophysiological pathway?

Yilmaz MI, Sonmez A, Saglam M, Yaman H, Cayci T, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Axelsson J.

Nephrol Dial Transplant. 2010 Oct;25(10):3250-6. doi: 10.1093/ndt/gfq159. Epub 2010 Mar 26.

PMID:
20348148

Supplemental Content

Support Center